Psychometric properties of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in male military personnel with and without PTSD

Abstract: Background: The 10-item Connor-Davidson Resilience Scale (CD-RISC-10) is a scale widely used to assess resilience among various clinical and nonclinical populations. Measurement invariance of a scale is essential for group comparison. However, to our knowledge, the psychometric properties, including the measurement invariance, validity and reliability, of the CD-RISC-10 in male military personnel with posttraumatic stress disorder (PTSD) are unknown. The current study aimed to determine the measurement invariance of the CD-RISC-10 and its validity and reliability in male military personnel with and without PTSD. Methods A total of 8089 male military personnel were enrolled in the study, 370 of whom were screened as having PTSD based on the screening criteria of a Posttraumatic Stress Disorder Checklist-Civilian score ≥38 and 7719 of whom did not have PTSD. Confirmatory factor analysis (CFA) was conducted to evaluate whether the scale had a single factor and to determine the measurement invariance in PTSD and non-PTSD samples. Results The Results showed that the CD-RISC-10 had satisfactory and reliable internal consistency and criterion-related validity among the PTSD (α = 0.91; r = -0.54, -0.44, -0.55, P<0.01) and non-PTSD (α = 0.94, r = -0.61, -0.49, -0.56, P<0.01) groups. The unidimensional structure of the CD-RISC-10 was verified by CFA in the PTSD and non-PTSD groups. Moreover, the scalar invariance of the CD-RISC-10 was established across PTSD and non-PTSD groups(△CFI = -0.002, △TLI = 0.001, △RMSEA =-0.001). Conclusions The Findings indicate that the CD-RISC-10 is an effective instrument for assessing psychological resilience across PTSD and non-PTSD male military personnel.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P